CN101560520A - Japanese encephalitis/dengue chimeric virus and application thereof - Google Patents

Japanese encephalitis/dengue chimeric virus and application thereof Download PDF

Info

Publication number
CN101560520A
CN101560520A CNA2009100852316A CN200910085231A CN101560520A CN 101560520 A CN101560520 A CN 101560520A CN A2009100852316 A CNA2009100852316 A CN A2009100852316A CN 200910085231 A CN200910085231 A CN 200910085231A CN 101560520 A CN101560520 A CN 101560520A
Authority
CN
China
Prior art keywords
prm
virus
replicon
proteic
jev
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2009100852316A
Other languages
Chinese (zh)
Inventor
李德新
韦艳
梁米芳
李川
王晓芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention
Original Assignee
National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention filed Critical National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention
Priority to CNA2009100852316A priority Critical patent/CN101560520A/en
Publication of CN101560520A publication Critical patent/CN101560520A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a Japanese encephalitis/dengue chimeric virus, which is obtained by replacing a prM/E gene in Japanese encephalitis cDNA clone with the prM/E gene of dengue virus type II. IFA and Western blot confirm that the chimeric virus can express E protein of a dengue virus and can stabilize passage in C6/36 cells. The invention lays a foundation for developing a dengue virus vaccine. The chimeric virus can be taken as a vaccine to immunize animals so as to enable the animals to obtain immune protection against the dengue virus.

Description

Japanese encephalitis/dengue chimeric virus and application thereof
Technical field
The present invention relates to the structure of japanese encephalitis virus (JEV) SA14-14-2 strain full length cDNA clone, the structure of replicon carrier.And the preparation method of Japanese encephalitis/dengue chimeric virus who the primary structure albumen prM/E albumen of encephalitis b virus is replaced to the corresponding protein of dengue virus.
Background technology
It is the widest popular arbovirus in the mankind nowadays that dengue virus (Dengue Virus DV) infects.Dengue virus is propagated by yellow-fever mosquito, nowadays almost in all torrid zones, subtropical zone distribution is arranged all.Estimate that according to WHO the whole world has 25~3,000,000,000 populations to face the danger of infecting dengue virus, annual nearly 5,000 ten thousand to 100,000,000 singapore hemorrhagic fever (Dengue fever DF) case takes place, symptoms such as the high heat of performance, headache, myalgia, arthrodynia and fash; This wherein has 500,000 examples to develop into even more serious dengue hemorrhagic fever (Dengue hemorrhagic fever DHF) and dengue shock syndrome (Dengue shocksyndrome DSS), and annual number because of dengue virus infection death is 2.5 ten thousand.In recent years along with global warming and tourist industry development, the geographic range of its media yellow-fever mosquito constantly enlarges, dengue virus infection is extensively sent out in worldwide, has become one of the widest, that number of the infected maximum, harm the is maximum important arbovirus that distributes in the world.
But, also have many problems of not understanding so far and solving about dengue virus and infection thereof, so that the control of dengue virus infection lacks very effective measure, particularly dengue virus vaccine research does not make substantial progress.Dengue virus has 4 serotypes, and 4 kinds of serotype viruses can cause morbidity.Present studies show that; antibody at a certain serotype of dengue virus does not have long-term provide protection to other serotypes; when infecting special-shaped virus once more; (antibody-dependentenhancement ADE) makes the patient produce even more serious dengue hemorrhagic fever and dengue shock syndrome because antibody relies on enhancement in meeting.So a kind of successful leather vaccine of stepping on must be stepped on leather to 4 types and can both produce protective immunity, can prevent the caused disease of dengue virus infection.WHO has been asserted dengue virus vaccine one of vaccine of first developing.And dengue virus vaccine also is the focus that the various countries scholar pays close attention to always, and nearly over 60 years, the effort that the leather vaccine is stepped in development never stops, and is used for clinical but still do not step on the leather vaccine at present.
Be accompanied by molecular biological develop rapidly, the new approaches that the leather vaccine is stepped in some researchs have been produced, the embedded virus vaccine is exactly wherein a kind of, its thinking is mainly: with a kind of weak viral disease poison is gene skeleton (being carrier), the corresponding gene of the structure gene (goal gene) of another kind virus being replaced vector virus has been built into infective embedded virus, and this embedded virus keeps the original weak malicious characteristic of vector virus and has the viral antigenicity of embedding.Mosaic can be induced stronger humoral immunization and cellular immunization with the form submission protective antigen of live virus.Using at present than successful carrier system in the research of dengue chimeric virus is respectively YF-17D, DEN2PDK-53 and aforesaid rDEN4 Δ 30.
Encephalitis b virus and dengue virus all belong to the member of flaviviridae Flavivirus together, are the sub-thread positive chain RNA virus, and genome is about 11kb, contain a single opening code-reading frame.Sequence in the gene is 5 ' NCR-C-PrM/M-E-NS 1-NS2B-NS3-NS4A-NS4B-NS5-NCR 3 ' in proper order, encode altogether 3 structural protein and 7 Nonstructural Proteins.Wherein the E albumen of E genes encoding is the virus surface envelope glycoprotein, has with cell surface receptor to combine, mediate the film fusion, induces important biomolecules such as producing neutralizing antibody to learn function, is viral most important antigen composition.The PrM/M albumen of PrM genes encoding also is considered to induce the antigenic component that produces neutralizing antibody.Nonstructural gene and non-coding region are main relevant with virus replication and protein translation.Encephalitis b virus SA14-14-2 strain is that encephalitis b virus virulent strain SA14 strain virus is gone down to posterity by suslik kidney monolayer cell long-term cultivation, by plaque screening and continue repeatedly to select had no pathogenicity in the mouse brain, by the go down to posterity stable low virulent strain of not reversion of mouse brain.This attenuated live vaccine has surpassed 200,000,000 in China's accumulative total inoculation number since approval is produced, and has good security.Yet, also encephalitis b virus SA14-14-2 strain is not used to make up the virus vaccines carrier at present, especially for the report that makes up dengue virus vaccine.
Summary of the invention
The objective of the invention is on the basis that makes up JEV SA14-14-2 strain vector system, prM/E gene among the encephalitis cDNA clone is replaced with the prM/E gene of dengue virus, obtain Japanese encephalitis/dengue chimeric virus, the prevention of possible dengue virus provides vaccine safely and effectively for future.
For achieving the above object, but first aspect present invention provides a kind of infective JEV cDNA clone that can generate the JEVRNA transcript of self-replacation, called after pBRF.
PBRF virus replication comprises plasmid vector and JEV SA14-14-2 full-length cDNA genomic clone.By the synthetic JEVRNA transcript of external run-off transcription (run-off transcription) production total length, allos protokaryon or eukaryotic promoter have been increased at the genomic 5 ' end of JEV.These promotors can be T7, CMV etc.Has unique restriction endonuclease sites as transcribing site out of control at the genomic 3 ' end of JEV SA14-14-2 full-length cDNA.
In embodiments of the present invention, JEV SA14-14-2 strain sequence (AF315119) according to the NCBI announcement, by two sections virus genome RNAs that increased of two eclipsed of RT-PCR technical point (comprising 3 ' terminal and 5 ' end), subsequently these two fragment order have been connected among the low copy plasmid pBR322.
For synthetic JEV by external run-off transcription (run-off transcription) production total length
The rna transcription thing has increased the T7 promoter sequence at the genomic 5 ' end of JEV, and it is terminal as transcribing site out of control to make unique restriction endonuclease sites SalI be positioned at genome 3 '.And in order to increase in-vitro transcription efficient, the present invention has increased by two guanylic acid bases (GG) after the T7 promoter sequence.
Transformation for the ease of the JEV carrier, the present invention will be arranged on the JEV genome ns3 gene the 963rd VITAMIN B4 A by site-directed mutagenesis technique and be mutated into thymus pyrimidine T, and therefore obtain the restriction endonuclease sites KpnI of a uniqueness in the JEV genome.
A second aspect of the present invention, replicon carrier based on above-mentioned replicon is provided, the proteic all or part of nucleic acid of the coding prM/E of replicon replaces with multiple clone site, and described part nucleotide sequence is meant coding proteic full sequence of prM and the proteic most of sequence of coding E.
In embodiments of the present invention, specifically having made up two can self-replacation and can express the JEV replicon carrier of yellow fluorescence protein (YFP), called after pFull Δ prM/E and pPartial Δ prM/E respectively.
Described replicon pFull Δ prM/E has lacked the proteic whole encoding sequences of prM/E of JEV fully, and has added multiple clone site (MCS) sequence that makes things convenient for exogenous gene cloning in the corresponding position.Multiple clone site is for holding 3 ' end to be followed successively by from 5 ': Age I, BSSH II, Xho I, XmaI.The sequence of pFull Δ prM/E such as SEQ ID NO1.Described replicon pPartial Δ prM/E has lacked the proteic proteic most encoding sequences of E that all reach of prM fully, has kept 71 amino acid coding of E PROTEIN C end.Because the contriver considers that this part sequence may be influential to the proteic expression of NS1.Equally, also added MCS sequence as replicon pFull Δ prM/E in the corresponding position.The sequence of pPartial Δ prM/E is shown in SEQ ID NO2.The in-vitro transcription RNA of above-mentioned two replicons all has the of self-replication capacity through real-time PCR experiment confirm in the BHK-21 cell.
Further, the present invention adopts conventional Protocols in Molecular Biology to insert the YFP reporter gene between the Age of above-mentioned two replicon carriers I and Xma I, and the YFP albumen in verified two replicon carriers has all obtained expression.
A third aspect of the present invention, Japanese encephalitis/dengue chimeric virus based on the JEV replicon carrier is provided, it is that the proteic all or part of nucleic acid of the coding prM/E of replicon is replaced with the proteic all or part of nucleotide sequence of dengue virus coding prM/E, or at the proteic all or part of nucleotide sequence of the multiple clone site insertion dengue virus coding prM/E of described replicon carrier, described part nucleotide sequence is meant coding proteic full sequence of prM and the proteic most of sequence of coding E.
In embodiments of the present invention, two strain embedded viruses have been made up, respectively called after JED 2V and JEED 21770V.
The embodiment of the invention adopts the RT-PCR technology to obtain the prM/E protein coding gene sequence of dengue virus 2 types (DV2) NGC strain.Between the Age I of above-mentioned pFull Δ prM/E replicon and XmaI, insert the prM/E protein coding gene of (DV2) NGC strain fully, make up mosaic clone pJEN-prM/E.Virus gene sequence among the pJEN-prM/E is shown in SEQ ID NO3.Between the AgeI of above-mentioned pPartial Δ prM/E replicon and Xma I, insert 71 amino acid whose prM/E protein coding gene sequences of intercepting E PROTEIN C end of (DV2) NGC strain, made up mosaic clone pJEE-1770.Virus gene sequence among the pJEE-1770 is shown in SEQ ID NO4.
Above-mentioned two mosaics clone's in-vitro transcription RNA can pack out Japanese encephalitis/dengue chimeric virus JED in the BHK-21 cell 2V and JEED 21770V.Described two strain embedded viruses confirm to express the E albumen of dengue virus through IFA and Western blot, and confirm to have chimeric nucleic acid through RT-PCR.And two strain embedded viruses all can be stablized in the C6/36 cell and go down to posterity.
Embedded virus of the present invention confirms to express the E albumen of dengue virus through IFA and Western blot, and can stablize in the C6/36 cell and go down to posterity, and behind the immune Balb/c mouse of two strain embedded viruses, can produce the proteic special IgG antibody of anti-DV2E.The present invention lays a good foundation for the dengue virus vaccine development.
Restriction enzyme site unique among the present invention is meant that the recognition sequence of this restriction enzyme site on certain nucleotide sequence is unique.
Description of drawings
Fig. 1 a is the stability experiment result of plasmid pBRF in E.coli DH5 α who contains the JEV full-length gene, 19329,7743,6223,4254,3472,2690,1882,1489,925,421 wherein: M1 is DNAmarker λ-EcoT14 (is followed successively by from top to bottom:, 74bp), 23130,9416,6557,4361,2322,2027,564 M2 is DNA marker λ-HindIII (is followed successively by from top to bottom:, 125bp), 1,2,3,4,5,6,7,8,9,10 be 1~10 generation plasmid.
Fig. 1 b is the stability experiment result of plasmid pBRF in E.coliXL10-Gold who contains the JEV full-length gene, 23130,9416,6557,4361,2322,2027,564 wherein: M1 is DNA marker λ-HindIII (is followed successively by from top to bottom:, 125bp), 19329,7743,6223,4254,3472,2690,1882,1489,925,421 M2 is DNA marker λ-EcoT14 (is followed successively by from top to bottom:, 74bp), 1,2,3,4,5,6,7,8,9,10 be 1~10 generation plasmid.
Fig. 1 C is the stability experiment result of plasmid pBRF in E.coliXL1-Blue who contains the JEV full-length gene, 19329,7743,6223,4254,3472,2690,1882,1489,925,421 wherein: M is DNAmarker λ-EcoT14 (is followed successively by from top to bottom:, 74bp), 1,2,3,4,5,6,7,8,9,10 be 1~10 generation plasmid.
Fig. 2 is Sf and the segmental policy map of Sp that amplification makes up the JEV replicon carrier.
Fig. 3 a is the flow cytometer detection figure behind the pJEfull-YFP RNA transfection BHK-21 cell.
Fig. 3 b is the flow cytometer detection figure behind the pJEpartial-YFP RNA transfection BHK-21 cell.
Fig. 4 a is JED 2V and JEED 21770V is to the pathology effect figure of BHK-21 cell.Wherein, A is normal BHK-21 cell, and B is JED 2V infected B HK-21 cell, C is JEED 21770V infected B HK-21 cell, D are JEV infected B HK-21 cells, and D is a DV2 infected B HK-21 cell.
Fig. 4 b is JED 2V and JEED 21770V is to the pathology effect figure of C6/36 cell.Wherein, A is normal C6/36 cell, and B is JED 2The C6/36 cell that V infects, C is JEED 2The C6/36 cell that 1770V infects, D are the C6/36 cells that JEV infects, and D is the C6/36 cell that DV2 infects.
Fig. 5 is JED 2V and JEED 2The identified by immunofluorescence figure of 1770V.A, B, C, D are respectively JED 2V, JEED 2The reaction result of C6/36 cell that 1770V, JEV infect and normal C6/36 cell and reorganization DV2EIII albumen rabbit immune serum.
Fig. 6 is JED 2V and JEED 2The westorn-blot of 1770V identifies figure.Wherein, M is molecular weight of albumen marker, and 1,2,3,4 is respectively JED 2V, JEED 2The reaction result of the C6/36 cell of 1770V, DV2, infection and normal C6/36 cell and reorganization DV2EIII albumen rabbit immune serum.
Fig. 7 is with JED 2V, JEED 2After 1770V, JEV, DV2,1640 kept around the liquid immunity Balb/C mouse, each organized the anti-DV2E protein I of mouse serum gG detected result relatively.
Embodiment
Below in conjunction with specific embodiment, further set forth the present invention.Should be understood that these embodiment only to be used to the present invention is described and be not used in and limit the scope of the invention.The experimental technique of unreceipted actual conditions in the following example, usually according to normal condition, as people such as Sambrook, molecular cloning: laboratory manual (New York:Cold Spring Harbor Laboratory Press, 1989) condition described in, or the condition of advising according to manufacturer.
The structure of embodiment 1:JEV full length cDNA clone
One, the cultivation of JEV SA14-14-2 strain and cell total rna extract
JEV SA14-14-2 strain is Chengdu Inst. of Biological Products's product, goes down to posterity in this chamber to cultivate to be no more than for 3 generations.JEV SA14-14-2 seed culture of viruses liquid is inoculated in the adherent BKH-21 cell that covers with (U.S. Stratagene), treats that cytopathy reaches ++ +~++ ++ the time, adopt Trizol reagent method to extract cell total rna.
Figure A20091008523100081
LS Reagent is an American I nvitrogen company product.
Two, the JEV cDNA of total length is incorporated among the plasmid pBR322 JEV cDNA clone of preparation total length
Adopt ThermoScript TMRT-PCR System (American I nvitrogen) is with synthetic cDNA first chain of JEV RNA reverse transcription.Adopt Elongase Amplification System (American I nvitrogen) to divide two sections full genomes of amplification JEV (the sub-called after U of 5 ' end half point fragment, the sub-called after L of 3 ' end half point fragment).The segmental primer of amplification U is: upstream primer: 5 '-CG GAATTCTAATACGACTCACTATAGGAGAAGTTTATCTGTGTGAACTTCTTGGCTTA-3 ' (the EcoR I restriction enzyme site of underscore for introducing, italic is the T7 promoter sequence, immediately following two guanylic acid bases with increase transcribe efficient thereafter), downstream primer is: 5 '-AAA GGATCCGT GGTACC(underscore is BamH I and Kpn I restriction enzyme site to AGGCGGGGTCGCTGTCATA-3 '.Wherein BamH I carries for the JEV genome, and Kpn I is that rite-directed mutagenesis obtains).The segmental primer of amplification L is: upstream primer: 5 '-GCCATCTTTATGACAGCGAC-3 ', downstream primer is: 5 ' CG GTCGACAGATCCTGTGTTCTTCCTCACCACCACGTACATACT-3 ' (the Sal I restriction enzyme site of underscore) for introducing.Above-mentioned U fragment and L fragment are connected to pGEM-T Easy Vector Systems (U.S. Promaga) obtain two kinds of positive colony pGEMT-U plasmids and pGEMT-L plasmid.With pGEMT-U plasmid EcoR I and BamH I double digestion, reclaiming molecular weight is the fragment band of 5.6kb size, be inserted between the EcoR I and BamH I restriction enzyme site of pBR322 carrier (Chinese magnificent company), identify the positive middle clone pBRU plasmid of acquisition through EcoR I and BamH I double digestion.The pGEMT-L plasmid with BamH I and Sal I double digestion, is reclaimed the fragment band that molecular weight is about the 5.4kb size, be inserted between the BamH I and Sal I restriction enzyme site of pBRU plasmid, cut evaluation, obtain JEV full length cDNA clone pBRF through enzyme.
Three, the stability experiment of JEV full length cDNA clone pBRF in intestinal bacteria
PBRF plasmid difference Transformed E .coli DH5 α, XL1-Blue, XL10-Gold three kinds of competent cells such as (being U.S. Stratagene company product) that will contain the JEV full length cDNA clone, the inoculation of picking mono-clonal contains antibiotic LB substratum and carried out 37 ℃ of shaking culture 12 hours, and carry out continuous passage respectively, passed for 10 generations altogether.Go down to posterity at every turn and adopt 10 4Extension rate, the incubation time that goes down to posterity are 12 hours, and each is for preparing plasmid DNA in a small amount, and agarose gel electrophoresis detects.The result shows that the pBRF plasmid can be stablized and goes down to posterity and the large fragment deletion of molecule does not take place in the XL1-Blue bacterial strain.The result is shown in Fig. 1 a, Fig. 1 b, Fig. 1 c.
The structure and the evaluation of embodiment 2:JEV replicon
One, the structure of JEV replicon
On above-mentioned JEV full length cDNA clone pBRF basis, with structural protein gene PrM/E disappearance, replace the multiple clone site that makes things convenient for exogenous gene cloning (multiple clone site, MCS).Multiple clone site selection principle: after the prM/E sequence of the complete sequence of multianalysis plasmid pBR322 and JEV SA14-14-2 strain, DV2NGC strain, not produce frameshit is principle, and selection cutting sequence is that Age I, BSSH II, Xho I, the Xma I of 6 bases is multiple clone site.The restriction enzyme site analysis software is the SeqBuilder module among the Lasergene.For fear of the lethality deletion, made up two replicons simultaneously, one for lacking the PrM/E gene fully; One keeps E gene C end 213bp, because the contriver considers that this part sequence may be significant with processing to the correct expression of NS1.
As shown in Figure 2, be template with JEV cDNA, with upstream primer: 5 '-AGGAGGGCCCGGTAAAAACC-3 ' and downstream primer: 5 '-cccgggctcgaggcgcgcaccggtGGCTCCTGCACAAGCTATG-3 ' (small letter is the MCS sequence) amplification S1 fragment; Upstream primer: 5 '-accggtgcgcgcctcgagcccgggGACACTGGATGTGCCATTGAC-3 ' (small letter is the MCS sequence) and downstream primer: 5 '-AAAGGATCCGTGGTACCAGGCGGGGTCGCTGTCATA-3 ' amplification S2 fragment, upstream primer: 5 '-accggtgcgcgcctcgagcccgggATTGGAGGGGTCTTCAACTC-3 ' (small letter is the MCS sequence) and downstream primer: 5 '-AAAGGATCCGTGGTACCAGGCGGGGTCGCTGTCATA-3 ' amplification S3 fragment, adopt the method amplification of merging PCR to transform the respective segments Sf and the Sp of carrier.Sf and Sp cut rear clone through Apa I and Kpn I enzyme and go in the pBRF that same enzyme is cut, the JEV replicon carrier plasmid of acquisition, called after pFull Δ prM/E and pPartial Δ prM/E respectively.The evaluation of cutting and check order of plasmid enzyme after preparation in a small amount.
Two, the preparation of JEV replicon in-vitro transcription thing RNA
As previously mentioned, the Sal I restriction enzyme site that is positioned at JEV replicon gene 3 ' end is the site out of control of in-vitro transcription.Therefore, earlier with plasmid pFull Δ prM/E and pPartial Δ prM/E through Sal I linearizing and purifying (purifying adopts Chinese T IANGEN gel Midi Purification Kit), adopt the RIBOMAX large scale RNA production system of Promega to prepare in-vitro transcription RNA.The preparation of 100 μ l reaction systems: 5 * transcript buffer, 20 μ l, rNTPs 30 μ l (rATP 25mM, rCTP25mM, rUTP 25mM, rGTP 8.33mM), m7G cap 5 μ l, enzemy mix (T7) 10 μ l, linearization plasmid 35 μ l (15~25ng/ μ l).Reaction system in 37 ℃ hatch 4h after, add 2 μ lDNAase and hatch 20min in 37 ℃.The in-vitro transcription thing adopts the RNeasyMini Kit purifying of QIAGEN company, and quantitatively the back packing is stored in-70 ℃.
Three, the self-replicating ability of Real-time PCR checking JEV replicon
Above-mentioned in-vitro transcription thing is by go down to posterity BHK-21 cell in 6 orifice plates of the dosage transfection in 4 μ g/ holes, and transfection method is that electricity changes, and electricity changes parameter and is: 850v, and 25uF, the resistance infinity shocks by electricity 2 times.24h, 48h, 72h, 96h harvested cell, the synthetic cDNA of reverse transcription adopt the platinum SYBR Green qPCR SuperMix-UDG of Invitrogen company to carry out Real-time PCR after transfection.
With GAPDH is the internal reference gene, with after 100 times of the cDNA dilutions as template, according to platinum SYBR Green qPCR SuperMix-UDG test kit specification sheets configuration PCR system.The PCR reaction system: PCR mix12.5 μ l, each 0.5 μ l of the upstream and downstream primer of 10 μ mol/L, cDNA (having diluted 100 times) 1 μ l, RNase-free water complement is long-pending to 20 μ l.The primer of amplification internal control gene GAPDH is: upstream primer 5 '-AAGGTGAAGGTCGGAGTCAACG-3 '; Downstream primer 5 '-GTCCCTGGAAGATGGTGATGG-3 '.The specific gene amplimer is: upstream primer 5 '-AGTGAAGAGGGTAGTAATGAG-3 '; Downstream primer 5 '-CCAAGTTCTCGTTTGAAACTA-3 '.Carry out Real-time PCR experiment at the IQ5 instrument.Every pipe PCR reaction triplicate.
The Ct value that reaction obtains through PCR is according to formula Δ Δ Ct=(Ct.Target-Ct.GAPDH) TX-(Ct.Target-Ct.GAPDH) T0(Target represents candidate gene, and GAPDH is an internal control gene), Tx represents random time point, T 0The expression control point) calculates gene is compared the Ct value with control cells in the different periods changing value Δ Δ Ct.When Δ Δ Ct was negative value, expression genetic expression was risen, Δ Δ Ct be on the occasion of the time, expression genetic expression decline.Equal 2 according to changing multiple | Δ Δ Ct|Obtain the multiple of changes in gene expression.
The result as shown in Table 1 and Table 2, RNA has in time to be increased and ever-increasing trend shows that the encephalitis b virus replicon of structure has the self-replicating ability.
Table 1 pFull Δ prM/E RNA Real-time PCR interpretation of result
Period Ct.target-Ct.GAPDH ΔΔCt 2 |ΔΔCt| Rise or descend
24h 7.98 / / /
48h 5.36 -2.62 6.15
72h 5.13 -0.23 1.17
96h -0.21 -5.34 40.50
Table 2 pPartial Δ prM/E RNA Real-time PCR interpretation of result
Period Ct.target-Ct.GAPDH ΔΔCt 2 |ΔΔCt| Rise or descend
24h 8.94 / / /
48h 7.75 -1.49 2.81
72h 7.35 -0.40 1.32
96h 3.66 -3.69 12.91
Four, the JEV replicon is identified the ability to express of foreign protein
With the plasmid PCDNA6.2/C-YFP-GW/TOPO (invitrogen company) that contains reporter gene YFP) be template, 5 ' AccggtAtggtgagcaagggc-3 ' (the Age I restriction enzyme site of underscore) and 5 ' for introducing- CccgggCttgtacagctggtc-3 ' (the Xma I restriction enzyme site of underscore for introducing) is a primer, employing Invitrogen company
Figure A20091008523100111
Taq DNA Polymerase High Fidelity amplification YFP gene.The gene fragment that obtains is cut through Age I and Xma I enzyme, carries out ligation with pFull Δ prM/E that cuts through same enzyme and pPartial Δ prM/E, connects product transformed into escherichia coli XL1-Blue, and plasmid is through the evaluation of cutting and check order of preparation back employing enzyme in a small amount.The plasmid called after pJEfull-YFP and the pJEpartial-YFP that make up.
PJEfull-YFP and pJEpartial-YFP are through behind Sal I linearizing and purifying, and in-vitro transcription obtains RNA.RNA is with go down to posterity BHK-21 cell in 6 orifice plates of the dosage in 4 μ g/ holes electric shock transfection.24h, 48h, 72h, 96h observe the YFP expression down in fluorescent microscope after transfection.Collect the capable flow cytometer of corresponding period cell simultaneously and detect, understand the positive cell rate of expressing YFP.Establish the negative contrast of normal BHK-21 cell simultaneously.
The result shows, in being inverted under the fluoroscope, transfection the BHK-21 cell of pJEfull-YFP RNA and pJEpartial-YFPRNA all can behind 24h, observe lasting enhanced fluorescent signal.The flow cytometer detected result shows that also the cell positive rate of express fluorescent protein all is the trend that increases gradually.The positive cell rate of different periods is respectively after the pJEfull-YFP RNA transfection: 3.0%, 5.8%, 6.9%, 13.9% (Fig. 3 a); That pJEpartial-YFP RNA is 4.1%, 7.1%, 7.9%, 15.6% (Fig. 3 b).
Embodiment 3: the preparation and the evaluation of encephalitis/step on leather 2 type embedded viruses
One, encephalitis/step on leather 2 type mosaics clone's structure
CDNA is a template with DV2 virus, adopt the RT-PCR technology to obtain DV2 (NGC strain, CDC virus disease institute) prM/E full-length gene (DV2-prM/E, 1983bp) and intercepted the gene fragment of prM/E gene 3 ' end 213nt (DV2-1770 1770bp) (adopts the Platinum Pfx archaeal dna polymerase amplification of Invitrogen company).The primer of amplification DV2-prM/E is: upstream primer 5 ' AccggtTTCCATTTAACC ACA-3 ' (underscore is the Age I restriction enzyme site for introducing), downstream primer 5 '- CccgggGGCCTGCACCATGAC-3 (the Xma I restriction enzyme site of underscore) for introducing; The primer of amplification DV2-1770 is: upstream primer is 5 '- AccggtTTCCATTTAACCACA-3 ' (underscore is the Age I restriction enzyme site for introducing), downstream primer be 5 '- CcccgggGGATCCAAAATCCCAAGCTG-3 ' (the Xma I restriction enzyme site of underscore) for introducing.Behind Age I and Xma I double digestion, reclaim the purpose fragment, be connected, connect product transformed into escherichia coli XL1-blue with pFull Δ prM/E that cuts through same enzyme and pPartial Δ prM/E orientation.Prepare in a small amount behind the plasmid and further through enzyme evaluations of cutting and check order, the recombinant plasmid of acquisition is distinguished called after pJEN-prM/E and pJEE-1770.DV2 gene order among the pJEN-prM/E is shown in SEQ IDNO3, and the DV2 gene order among the pJEE-1770 is shown in SEQ ID NO4.
Two, the preparation of mosaic in-vitro transcription thing RNA
Plasmid pJEN-prM/E and pJEE-1770 adopt the RIBOMAX large scale RNA production system of Promega to prepare in-vitro transcription RNA behind Sal I linearizing and purifying.The preparation of 100 μ l reaction systems: 5 * transcript buffer, 20 μ l, rNTPs 30 μ l (rATP25mM, rCTP 25mM, rUTP 25mM, rGTP 8.33mM), m7G cap 5ul, enzemymix (T7) 10 μ l, linearization plasmid 35 μ l (15~25ng/ μ l).Reaction system in 37 ℃ hatch 4h after, add 2 μ l DNAase and hatch 20min in 37 ℃, with the digestion template DNA.The in-vitro transcription thing adopts the RNeasy Mini Kit purifying of QIAGEN company, and quantitatively the back packing is stored in-70 ℃.
Three, encephalitis/step on leather 2 rescues of type embedded virus in the BHK-21 cell
Will be in the T25 square vase the adherent BHK-21 cell that covers with 10% trysinization, with the DMEM nutrient solution re-suspended cell that contains 10%FBS, the centrifugal 5min of 400g; Wash cell twice with aseptic cold PBS, cell is resuspended among the 400ulPBS, behind adding 10ug in-vitro transcription RNA and the abundant mixing, on Biorad Gene Pulser, carry out electricity immediately and change.Electricity changes parameter: twice of voltage 850v, electric capacity 25uF, resistance ∞, pulse.Cell after the electric shock is placed 5min on ice, change over to immediately and add 2.5ml in advance and contain in six orifice plates of DMEM nutrient solution of 10%FBS, 37 ℃ of cultivations are changed liquid once behind the cell attachment.If the negative contrast of normal bhk cell through electric shock.Day by day observation of cell form.
The result shows, behind the in-vitro transcription thing transfection BHK-21 cell of pJEN-prM/E and pJEE-1770, can be observed typical CPE, show as cell rounding, come off in 5~7 days, similar to DV2 and JEV to the pathology effect of BHK-21 cell, and negative control cell does not have pathology.The results are shown in Figure 4a.With cell that CPE occurs together with supernatant multigelation 3 times after, the centrifugal 5min of 4000rpm, the results supernatant is preserved as seed culture of viruses.The embedded virus called after JED that obtains 2V and JEED 21770V.Four, the cultivation of going down to posterity of encephalitis/step on leather 2 type embedded viruses
Get above-mentioned JED 2V and JEED 21770V seed culture of viruses supernatant 0.5ml is inoculated in bhk cell and the C6/36 cell that passes in the T25 square vase respectively, and behind 37 ℃ and 28 ℃ absorption 1h, add the cell maintenance medium that contains 2%FBS and continue to cultivate, and observation of cell form day by day.JED as a result 2V and JEED 2In 1770V 5 generations of blind passage in the BHK-21 cell, all can not detect virus.And the embedded virus JED that in the C6/36 cell, cultivates 2V and JED 21770V can make cell typical cytopathic occur in about 4 days in infection, shows as the swelling and the gathering of cell, and is similar to the pathology effect of C6/36 cell to DV2 and JEV, but the buildup effect degree of pair cell is not as good as two parent's strain.The results are shown in Figure 4b.
Five, the RT-PCR of encephalitis/step on leather 2 type embedded viruses identifies
Get and inoculated s-generation JED 2V and JED 21770V also the C6/36 cell of CPE occurs, carries the synthetic cDNA of RNA and reverse transcription.With this cDNA is template, carry out pcr amplification at the zone design primer that is positioned at beyond the embedded virus prM/E gene, upstream primer is 5 '-CGAGAACTTGGAACACTCATTGACG-3 ', downstream primer is 5 '-GCGCTTTGTGGACGATCTTCGCTAG-3 ', and amplified production send order-checking after 1% agarose gel electrophoresis purifying reclaims.
The two fragment about 2100bp that all increases as a result.With the negative contrast of RNA before the transfection, do not diffuse into the purpose band, show that dna profiling has digested fully.With this sequencing fragment, comparison result is found to be the mosaic gene of DV2prM/E gene and JEV C and NS1.The genetic marker site that the Age I that introduces when making up the mosaic clone and two restriction enzyme sites of Xma I also can be used as embedded virus, sequencing result has all detected this two marks.
Six, the indirect immunofluorescence of encephalitis/step on leather 2 type embedded viruses is identified
Get and inoculated JED 2V and JED 21770V also the cell of CPE occurs, cell is blown down the back wash 2 times with PBS.Cell is resuspended among the PBS, preparation antigen sheet, and cold acetone is 15min fixedly.Rabbit anteserum with DV2 reorganization EIII protein immunization is one anti-(1: 200), and the goat-anti rabbit anteserum of FITC mark is two anti-(1: 100; U.S. Sigma), fluorescent microscope is observed the antigen sheet down.The result can observe specific fluorescence under fluorescent microscope, C6/36 cell that JEV infects and normal C6/36 cell be not rabbit anteserum reaction therewith all.JED 2V and JED 2The C6/36 cell that 1770V infects does not react with normal rabbit serum yet.The results are shown in Figure 5.
Seven, the western-blot of encephalitis/step on leather 2 type embedded viruses identifies
Add lysis liquid in having inoculated JED2V and JED21770V and having occurred placing 30min on ice in the cell of CPE.Get 40 μ l and add 10 μ l, 5 * protein loading buffer, boil 3min.The centrifugal 10min of 12000rpm gets the capable SDS-PAGE electrophoresis of supernatant, through half-dried electric commentaries on classics method, albumen is transferred on the PDVF film, rabbit anteserum with DV2 reorganization EIII protein immunization is one anti-(1: 200), and the goat-anti rabbit anteserum of HRP mark is two anti-(1: 2000 U.S. Sigma), the DAB colour developing.With the positive contrast of C6/36 cell pyrolysis liquid that DV2 infects, the normal negative contrast of C6/36 cell, the result is except that negative control, and is consistent with expection in the equal bands visible in 60KD place, sees Fig. 6.Eight, the immunogenicity experiments of encephalitis/step on leather 2 type embedded viruses
(1) immunogenic preparation
Be harvested from cultivate in the C6/36 cell the 4th generation the embedded virus supernatant, cross the 0.45um filter membrane.Adopt the TCID50 experiment to determine virus titer, adopt the RPMI-1640 nutrient solution that contains 1%FBS that virus titer is adjusted to 10 5Standby.The DV2 and the JEV virus liquid that prepare identical titre with method.
(2) laboratory animal and grouping
25 of healthy Balb/C female mices are provided by the Chinese Academy of Medical Sciences, China Concord Medical Science University institute of lab animals.Laboratory animal is divided into 5 groups (5/group) at random: (1) JED2V immune group; (2) JED21770V immune group; (3) DV2 immune group; (4) JEV immune group; (5) negative control group (the RPMI-1640 nutrient solution that contains 1%FBS).
(3) immunization protocol
Get above-mentioned seed culture of viruses liquid and negative control nutrient solution, fully behind the mixing,, only inoculate mouse by 200ul/ with the abdominal injection approach.The 4th week of immunity back is put to death mouse, collects carotid artery blood, and separation of serum is standby.
(4) ELISA detects the anti-DV2E protein antibodies of serum
1) antigen coated: the DV2EIII albumen with the prokaryotic expression purifying is antigen, adds in 96 orifice plates by the 100ng/ hole, and 4 ℃ are spent the night, and PBST washes plate 3 times;
2) every hole adds 5% skimmed milk of the aseptic PBS preparation of 300ul, 37 ℃ of sealing 2h, and PBST washes plate 3 times;
3) mice serum collected is diluted with 5% skimmed milk, since 1: 100, make 2 times of serial dilutions, add in 96 orifice plates by the 100ul/ hole, hatch 1h for 37 ℃, PBST washes plate 6 times;
4) adding two resists: by dilution in 1: 500,1h was hatched for 37 ℃ in the 100ul/ hole to the sheep anti-mouse igg of HRP mark with 5% skimmed milk, and PBST washes plate 6 times;
5) colour developing: add substrate A liquid, the every hole 50ul of B liquid, lucifuge is placed 10min.2N H 2SO 4The 50ul termination reaction.
6) microplate reader detects A 450
(5) neutralization test detects the neutralization activity of serum
1), treats that cell grows to individual layer with BHK-21 passage to 96 orifice plate;
2) with the mouse immune serum collected in 56 ℃ of deactivation 30min, cross the 0.45um filter membrane;
3) with inactivated serum with keeping liquid since 1: 8, make 2 times of doubling dilutions, mixed 37 ℃ of incubation 1h by 1: 1 with the DV2 of 100TCID50;
4) nutrient solution in sucking-off 96 orifice plates is washed 1 time with keeping liquid;
5) press in the adding of 200ul/ hole and serum, each extent of dilution is done 4 multiple holes;
6) 37 ℃, 5%CO 2Condition is cultivated, and observes pathology day by day, observes altogether 7 days.
7) with four multiple Kong Jun do not occur observable cytopathic serum dilution as antibody neutralization tire.
The result shows, each extent of dilution OD of the mouse serum of embedded virus and DV2 immunity 450All be higher than JEV immune group and negative control group (P<0.05), embedded virus immunity Balb/C mouse is described after, can produce special anti-DV2E protein I gG antibody.Specifically see Table 3 and Fig. 7.The serum antibody titer of Balb/C mouse after the two strain embedded virus immunity is answered about 1: 10.Specifically see Table 4.
Table 3 is respectively organized mouse anti DV2E protein I gG detected result
Group 1∶100 1∶200 1∶400 1∶800
JED 2V 0.5267±0.1127 0.2276±0.0517 0.1278±0.02969 0.0905±0.0151
JED 21770V 0.5585±0.2694 0.2421±0.1372 0.1352±0.0642 0.0982±0.0288
DV2 0.7499±0.0834 0.3083±0.0357 0.2018±0.0226 0.1209±0.0221
JEV 0.1255±0.0193 0.0692±0.0082 0.0496±0.0009 0.0354±0.0030
Negative control 0.1368±0.0407 0.0824±0.0074 0.0476±0.0067 0.0398±0.0085
Table 4 is respectively organized mice serum NAT detected result
Figure A20091008523100161
Annotate: data are expressed as in the table: the number of animals/actual detected number of animals that reaches certain antibody titer.
Sequence table
<110〉CDC virus disease institute
<120〉Japanese encephalitis/dengue chimeric virus and application thereof
<130>KHP09112373.6
<160>26
<170>PatentIn version 3.5
<210>1
<211>9019
<212>DNA
<213〉artificial sequence
<400>1
taatacgact cactatagga gaagtttatc tgtgtgaact tcttggctta gtatcgtaga 60
gaagaatcga gagattagtg cagtttaaac agttttttag aacggaagat aaccatgact 120
aaaaaaccag gagggcccgg taaaaaccga gctatcaata tgctgaaacg cggcctaccc 180
cgcgtattcc cactagtggg agtgaagagg gtagtaatga gcttgttgga cggcagaggg 240
ccagtacgtt tcgtgctggc tcttatcacg ttcttcaagt ttacagcatt agccccgacc 300
aaggcgcttt caggccgatg gaaagcagtg gaaaagagtg tggcaatgaa acatcttact 360
agtttcaaac gagaacttgg aacactcatt gacgccgtga acaagcgggg cagaaagcaa 420
aacaaaagag gaggaaatga aggctcaatc atgtggctcg cgagcttggc agttgtcata 480
gcttgtgcag gagccaccgg tgcgcgcctc gagcccgggg acactggatg tgccattgac 540
atcacgagaa aagagatgag atgtggaagt ggcatcttcg tgcacaacga cgtggaagcc 600
tgggtggata ggtataaata tttgccagaa acgcccagat ccctagcgaa gatcgtccac 660
aaagcgcaca aggaaggcgt gtgcggagtc agatctgtca ctagactgga gcaccaaatg 720
tgggaagccg taagggacga attgaacgtc ctgctcaaag agaatgcagt ggacctcagt 780
gtggttgtga acaagcccgt gggaagatat cgctcagccc ctaaacgcct atccatgacg 840
caagagaagt ttgaaatggg ctggaaagca tggggaaaaa gcatcctctt tgccccggaa 900
ttggctaact ccacatttgt cgtagatgga cctgagacaa aggaatgccc tgatgagcac 960
agagcttgga acagcatgca aatcgaagac ttcggctttg gcatcacatc aacccgtgtg 1020
tggctgaaaa ttagagagga gagcactgac gagtgtgatg gagcgatcat aggcacggct 1080
gtcaaaggac atgtggcagt ccatagtgac ttgtcgtact ggattgagag tcgctacaac 1140
gacacatgga aacttgagag ggcagtcttt ggagaggtca aatcttgcac ttggccagag 1200
acacacaccc tttggggaga tgatgttgag gaaagtgaac tcatcattcc gcacaccata 1260
gccggaccaa aaagcaagca caatcggagg gaagggtata agacacaaaa ccagggacct 1320
tgggatgaga atggcatagt cttggacttt gattattgcc cagggacaaa agtcaccatt 1380
acagaggatt gtagcaagag aggcccttcg gtcagaacca ctactgacag tggaaagttg 1440
atcactgact ggtgctgtcg cagttgctcc cttccgcccc tacgattccg gacagaaaat 1500
ggctgctggt acggaatgga aatcagacct gttatgcatg atgaaacaac actcgtcaga 1560
tcacaggttc atgctttcaa aggtgaaatg gttgaccctt ttcagctggg ccttctggtg 1620
atgtttctgg ccacccagga agtccttcgc aagaggtgga cggccagatt gaccattcct 1680
gcggttttgg gggtcctact tgtgctgatg cttgggggta tcacttacac tgatttggcg 1740
aggtatgtgg tgctagtcgc tgctgctttc gcagaggcca acagtggagg agacgtcctg 1800
caccttgctt tgattgctgt ttttaagatc caaccagcat ttttagtgat gaacatgctt 1860
agcacgagat ggacgaacca agaaaacgtg gttctggtcc taggggctgc ctttttccaa 1920
ttggcctcag tagatctgca aataggagtc cacggaatcc tgaatgccgc cgctatagca 1980
tggatgattg tccgagcgat caccttcccc acaacctcct ccgtcaccat gccagtctta 2040
gcgcttctaa ctccggggat gagggctcta tacctagaca cttacagaat catcctcctc 2100
gtcataggga tttgctccct gctgcacgag aggaaaaaga ccatggcgaa aaagaaagga 2160
gctgtactct tgggcttagc gctcacatcc actggatggt tctcgcccac cactatagct 2220
gccggactaa tggtctgcaa cccaaacaag aagagagggt ggccagctac tgagtttttg 2280
tcggcagttg gattgatgtt tgccatcgta ggtggtttgg ccgagttgga tattgaatcc 2340
atgtcaatac ccttcatgct ggcaggtctc atggcagtgt cctacgtggt gtcaggaaaa 2400
gcaacagata tgtggcttga acgggccgcc gacatcagct gggatatggg tgctgcaatc 2460
acaggaagca gtcggaggct ggatgtgaaa ctggatgatg acggagattt tcacttgatt 2520
gatgatcccg gtgttccatg gaaggtctgg gtcctgcgca tgtcttgcat tggcttagcc 2580
gccctcacgc cttgggccat cgttcccgcc gctttcggtt attggctcac tttaaaaaca 2640
acaaaaagag ggggcgtgtt ttgggacacg ccatccccaa aaccttgctc aaaaggagac 2700
accactacag gagtctaccg aattatggct agagggattc ttggcactta ccaggccggc 2760
gtcggagtca tgtacgagaa tgttttccac acactatggc acacaactag aggagcagcc 2820
attgtgagtg gagaaggaaa attgacgcca tactggggta gtgtgaaaga agaccgcata 2880
gcttacggag gcccatggag gtttgaccga aaatggaatg gaacagatga cgtgcaagtg 2940
atcgtggtag aaccggggaa gggcgcagta aacatccaga caaaaccagg agtgtttcgg 3000
actcccttcg gggaggttgg ggctgttagt ctggattacc cgcgaggaac atccggctca 3060
cccattctgg attccaatgg agacattata ggcctatacg gcaatggagt tgagcttggc 3120
gatggctcat acgtcagcgc catcgtgcag ggtgaccgtc aggaggaacc agtcccagaa 3180
gcttacaccc caaacatgtt gagaaagaga cagatgactg tgctagattt gcaccctggt 3240
tcagggaaaa ccaggaaaat tctgccacaa ataattaagg acgctatcca gcagcgccta 3300
agaacagctg tgttggcacc gacgcgggtg gtagcagcag aaatggcaga agttttgaga 3360
gggctcccag tacgatatca aacttcagca gtgcagagag agcaccaagg gaatgaaata 3420
gtggatgtga tgtgccacgc cactctgacc catagactga tgtcaccgaa cagagtgccc 3480
aactacaacc tatttgtcat ggatgaagct catttcaccg acccagccag tatagccgca 3540
cgaggataca ttgctaccaa ggtggaatta ggggaggcag cagccatctt tatgacagcg 3600
accccgcctg gtaccacgga tccttttcct gactcaaatg ccccaatcca tgatttgcaa 3660
gatgagatac cagacagggc atggagcagt ggatacgaat ggatcacaaa atatgcgggt 3720
aaaaccgtgt ggtttgtggc gagcgtaaaa atggggaatg agattgcaat gtgcctccaa 3780
agagcgggga aaaaggtcat ccaactcaac cgcaagtcct atgacacaga atacccaaaa 3840
tgtaagaatg gagactggga ttttgtcatt accaccgaca tctctgaaat gggggccaac 3900
ttcggtgcga gcagggtcat cgactgtaga aagagcgtga aacccaccat cttagaagag 3960
ggagaaggca gagtcatcct cggaaaccca tctcccataa ccagtgcaag cgcagctcaa 4020
cggaggggca gagtaggcag aaaccccaat caagttggag atgaatacca ctatgggggg 4080
gctaccagtg aagatgacag taacctagcc cattggacag aggcaaagat catgttagac 4140
aacatacaca tgcccaatgg actggtgacc cagctctatg gaccagagag ggaaaaggct 4200
ttcacaatgg atggcgaata ccgtctcaga ggtgaagaaa agaaaaactt cttagagctg 4260
cttaggacgg ctgacctccc ggtgtggctg gcctacaagg tggcgtccaa tggcatccag 4320
tacaccgaca gaaagtggtg ttttgatggg ccgcgtacga atgccatact ggaggacaac 4380
accgaggtag agatagtcac ccggatgggt gagaggaaaa tcctcaagcc gagatggctt 4440
gatgcaagtg tttatgcaga tcaccaggcc ctcaagtggt tcaaagactt tgcagcaggg 4500
aagagatcag ccgttagctt catagaggtg ctcggtcgca tgcctgagca tttcatggga 4560
aagacgcggg aagctttaga caccatgtac ttggttgcaa cggctgagaa aggtgggaaa 4620
gcacaccgaa tggctctcga agagctgcca gatgcactgg aaaccatcac acttattgtc 4680
gccattactg tgatgacagg aggattcttc ctactaatga tgcagcgaaa gggtataggg 4740
aagatgggtc ttggagctct agtgctcaca ctagctacct tcttcctgtg ggcggcagag 4800
gttcctggaa ccaaaatagc agggaccctg cagatcgccc tgctgctgat ggtggttccc 4860
atcccagaac cggaaaaaca gaggtcacag acagataacc aactggcggt gtttctcatc 4920
tgtgtcttga ccgtggttgg agtggtggca gcaaacgagt acgggatgct agaaaaaacc 4980
aaagcggatc tcaagagcat gtttggcgga aagacgcagg catcaggact gactggattg 5040
ccaagcatgg cactggacct gcgtccagcc acagcctggg cactgtatgg ggggagcaca 5100
gtcgtgctaa cccctcttct gaagcacctg atcacgtcgg aatacgtcac cacatcgcta 5160
gcttcaatta actcacaagc tggctcatta ttcgtcttgc cacgaggcgt gccttttacc 5220
gacctagact tgactgttgg cctcgtcttc cttggctgtt ggggtcaagt caccctcaca 5280
acgtttctga cagccatggc tctggcgaca cttcactatg ggtacatgct ccctggatgg 5340
caagcagaag cactcagggc tgcccagaga aggacagcgg ctggaataat gaagaatgcc 5400
gttgttgacg gaatggtcgc cactgatgtg cctgaactgg aaaggactac tcctctgatg 5460
caaaagaaag tcggacaggt gctcctcata ggggtaagcg tggcagcgtt cctcgtcaac 5520
cctaatgtca ccactgtgag agaagcaggg gtgttggtga cggcggctac gcttactttg 5580
tgggacaatg gagccagtgc cgtttggaat tccaccacag ccacgggact ctgccatgtc 5640
atgcgaggta gctacctggc tggaggctcc attgcttgga ctctcatcaa gaacgctgat 5700
aagccctcct tgaaaagggg aaggcctggg ggcaggacgc taggggagca ttggaaggaa 5760
aaactaaatg ccatgagtag agaagagttt tttaaatacc ggagagaggc cataatcgag 5820
gtggaccgca ctgaagcacg cagggccaga cgtgaaaata acatagtggg aggacatccg 5880
gtttcgcgag gctcagcaaa actccgttgg ctcgtggaga aaggatttgt ctcgccaata 5940
ggaaaagtca ttgatctagg gtgtgggcgt ggaggatgga gctactacgc agcaaccctg 6000
aagaaggtcc aggaagtcag aggatacacg aaaggtgggg cgggacatga agaaccgatg 6060
ctcatgcaga gctacggctg gaacctggtc tccctgaaga gtggagtgga cgtgttttac 6120
aaaccttcag agcccagtga taccctgttc tgtgacatag gggaatcctc cccaagtcca 6180
gaagtagaag aacaacgcac actacgcgtc ctagagatga catctgactg gttgcaccga 6240
ggacctagag agttctgcat taaagttctc tgcccttaca tgcccaaggt tatagaaaaa 6300
atggaagttc tgcagcgtcg cttcggaggt gggctagtgc gtctccccct gtcccgaaac 6360
tccaatcacg agatgtattg ggttagtgga gccgctggca atgtggtgca cgctgtgaac 6420
atgaccagcc aggtattact ggggcgaatg gatcgcacag tgtggagagg gccaaagtat 6480
gaggaagatg tcaacctagg gagcggaaca agagccgtgg gaaagggaga agtccatagc 6540
aatcaggaga aaatcaagaa gagaatccag aagcttaaag aagaattcgc cacaacgtgg 6600
cacaaagacc ctgagcatcc ataccgcact tggacatacc acggaagcta tgaagtgaag 6660
gctactggct cagccagctc tctcgtcaac ggagtggtga agctcatgag caaaccttgg 6720
gacgccattg ccaacgtcac caccatggcc atgactgaca ccaccccttt tggacagcaa 6780
agagttttca aggagaaagt tgacacgaag gctcctgagc caccagctgg agccaaggaa 6840
gtgctcaacg agaccaccaa ctggctgtgg gcctacttgt cacgggaaaa aagaccccgc 6900
ttgtgcacca aggaagaatt cattaagaaa gttaacagca acgcggctct tggagcagtg 6960
ttcgctgaac agaatcaatg gagcacggcg cgtgaggctg tggatgaccc gcggttttgg 7020
gagatggttg atgaagagag ggaaaaccat ctgcgaggag agtgtcacac atgtatctac 7080
aacatgatgg gaaaaagaga gaagaagcct ggagagtttg gaaaagctaa aggaagcagg 7140
gccatttggt tcatgtggct tggagcacgg tatctagagt ttgaagcttt ggggttcctg 7200
aatgaagacc attggctgag ccgagagaat tcaggaggtg gagtggaagg ctcaggcgtc 7260
caaaagctgg ggtacatcct ccgtgacata gcaggaaagc aaggagggaa aatgtacgct 7320
gatgataccg ccgggtggga cactagaatt accagaactg atttagaaaa tgaagctaag 7380
gtactggagc tcctagacgg tgaacaccgc atgctcgccc gagccataat tgaactgact 7440
tacaggcaca aagtggtcaa ggtcatgaga cctgcagcag aaggaaagac cgtgatggac 7500
gtgatatcaa gagaagatca aagggggagt ggacaggtgg tcacttatgc tcttaacact 7560
ttcacgaaca tcgctgtcca gctcgtcagg ctgatggagg ctgagggggt cattggacca 7620
caacacttgg aacatctacc taggaaaaac aagatagctg tcaggacctg gctctttgag 7680
aatggagagg agagagtgac caggatggcg atcagcggag acgactgtgc cgtcaaaccg 7740
ctggacgaca gattcgccac agccctccac ttcctcaacg caatgtcaaa ggtcagaaaa 7800
gacatccagg aatggaagcc ttcgcatggc tggcacgatt ggcagcaagt tcccttctgt 7860
tctaaccatc ttcaggagat tgtgatgaaa gatggaagga gtatagttgt cccgtgcaga 7920
ggacaggatg agctgatagg cagggctcgc atctctccag gagctggatg gaatgtgaag 7980
gacacagctt gcctggccaa agcatatgca cagatgtggc tactcctata cttccatcgc 8040
agggacttgc gtctcatggc aaatgcgatt tgctcagcag cgccagtaga ttgggtgccc 8100
acaggcagga catcctggtc aatacactcg aaaggagagt ggatgaccac ggaagacatg 8160
ctgcaggtct ggaacagagt ttggattgaa gaaaatgaat ggatgatgga caagactcca 8220
atcacaagct ggacagacgt tccgtatgtg ggaaagcgcg aggacatctg gtgtggcagc 8280
ctcatcggaa cgcgatccag agcaacctgg gctgagaaca tctatgcggc gataaaccag 8340
gttagagctg tcattgggaa agaaaattat gttgactaca tgacctcact caggagatac 8400
gaagacgtct tgatccagga agacagggtc atctagtgtg atttaaggta gaaaagtaga 8460
ctatgtaaac aatgtaaatg agaaaatgca tgcatatgga gtcaggccag caaaagctgc 8520
caccggatac tgggtagacg gtgctgcctg cgtctcagtc ccaggaggac tgggttaaca 8580
aatctgacaa cagaaagtga gaaagccctc agaaccgtct cggaagtagg tccctgctca 8640
ctggaagttg aaagaccaac gtcaggccac aaatttgtgc cactccgcta gggagtgcgg 8700
cctgcgcagc cccaggagga ctgggttacc aaagccgttg aggcccccac ggcccaagcc 8760
tcgtctagga tgcaatagac gaggtgtaag gactagaggt tagaggagac cccgtggaaa 8820
caacaacatg cggcccaagc cccctcgaag ctgtagagga ggtggaagga ctagaggtta 8880
gaggagaccc cgcacttgca tcaaacagca tattgacacc tgggaataga ctgggagatc 8940
ttctgctcta tctcaacatc agctactagg cacagagcgc cgaagtatgt acgtggtggt 9000
gaggaagaac acaggatct 9019
<210>2
<211>9232
<212>DNA
<213〉artificial sequence
<400>2
taatacgact cactatagga gaagtttatc tgtgtgaact tcttggctta gtatcgtaga 60
gaagaatcga gagattagtg cagtttaaac agttttttag aacggaagat aaccatgact 120
aaaaaaccag gagggcccgg taaaaaccga gctatcaata tgctgaaacg cggcctaccc 180
cgcgtattcc cactagtggg agtgaagagg gtagtaatga gcttgttgga cggcagaggg 240
ccagtacgtt tcgtgctggc tcttatcacg ttcttcaagt ttacagcatt agccccgacc 300
aaggcgcttt caggccgatg gaaagcagtg gaaaagagtg tggcaatgaa acatcttact 360
agtttcaaac gagaacttgg aacactcatt gacgccgtga acaagcgggg cagaaagcaa 420
aacaaaagag gaggaaatga aggctcaatc atgtggctcg cgagcttggc agttgtcata 480
gcttgtgcag gagccaccgg tgcgcgcctc gagcccggga ttggaggggt cttcaactcc 540
ataggaagag ccgttcacca agtgtttggt ggtgccttca gaacactctt tgggggaatg 600
tcttggatca cacaagggct aatgggtgcc ctactgctct ggatgggcgt caacgcacga 660
gaccgatcaa ttgctttggc cttcttagcc acaggaggtg tgctcgtgtt cttagcgacc 720
aatgtgcatg ctgacactgg atgtgccatt gacatcacaa gaaaagagat gagatgtgga 780
agtggcatct tcgtgcacaa cgacgtggaa gcctgggtgg ataggtataa atatttgcca 840
gaaacgccca gatccctagc gaagatcgtc cacaaagcgc acaaggaagg cgtgtgcgga 900
gtcagatctg tcactagact ggagcaccaa atgtgggaag ccgtaaggga cgaattgaac 960
gtcctgctca aagagaatgc agtggacctc agtgtggttg tgaacaagcc cgtgggaaga 1020
tatcgctcag cccctaaacg cctatccatg acgcaagaga agtttgaaat gggctggaaa 1080
gcatggggaa aaagcatcct ctttgccccg gaattggcta actccacatt tgtcgtagat 1140
ggacctgaga caaaggaatg ccctgatgag cacagagctt ggaacagcat gcaaatcgaa 1200
gacttcggct ttggcatcac atcaacccgt gtgtggctga aaattagaga ggagagcact 1260
gacgagtgtg atggagcgat cataggcacg gctgtcaaag gacatgtggc agtccatagt 1320
gacttgtcgt actggattga gagtcgctac aacgacacat ggaaacttga gagggcagtc 1380
tttggagagg tcaaatcttg cacttggcca gagacacaca ccctttgggg agatgatgtt 1440
gaggaaagtg aactcatcat tccgcacacc atagccggac caaaaagcaa gcacaatcgg 1500
agggaagggt ataagacaca aaaccaggga ccttgggatg agaatggcat agtcttggac 1560
tttgattatt gcccagggac aaaagtcacc attacagagg attgtagcaa gagaggccct 1620
tcggtcagaa ccactactga cagtggaaag ttgatcactg actggtgctg tcgcagttgc 1680
tcccttccgc ccctacgatt ccggacagaa aatggctgct ggtacggaat ggaaatcaga 1740
cctgttatgc atgatgaaac aacactcgtc agatcacagg ttcatgcttt caaaggtgaa 1800
atggttgacc cttttcagct gggccttctg gtgatgtttc tggscaccca ggaagtcctt 1860
cgcaagaggt ggacggccag attgaccatt cctgcggttt tgggggtcct acttgtgctg 1920
atgcttgggg gtatcactta cactgatttg gcgaggtatg tggtgctagt cgctgctgct 1980
ttcgcagagg ccaacagtgg aggagacgtc ctgcaccttg ctttgattgc tgtttttaag 2040
atccaaccag catttttagt gatgaacatg cttagcacga gatggacgaa ccaagaaaac 2100
gtggttctgg tcctaggggc tgcctttttc caattggcct cagtagatct gcaaatagga 2160
gtccacggaa tcctgaatgc cgccgctata gcatggatga ttgtccgagc gatcaccttc 2220
cccaccacct cctccgtcac catgccagtc ttagcgcttc taactccggg gatgagggct 2280
ctatacctag acacttacag aatcatcctc ctcgtcatag ggatttgctc cctgctgcac 2340
gagaggaaaa agaccatggc gaaaaagaaa ggagctgtac tcttgggctt agcgctcaca 2400
tccactggat ggttctcgcc caccactata gctgccggac taatggtctg caacccaaac 2460
aagaagagag ggtggccagc tactgagttt ttgtcggcag ttggattgat gtttgccatc 2520
gtaggtggtt tggccgagtt ggatattgaa tccatgtcaa tacccttcat gctggcaggt 2580
ctcatggcag tgtcctacgt ggtgtcagga aaagcaacag atatgtggct tgaacgggcc 2640
gccgacatca gctgggatat gggtgctgca atcacaggaa gcagtcggag gctggatgtg 2700
aaactggatg atgacggaga ttttcacttg attgatgatc ccggtgttcc atggaaggtc 2760
tgggtcctgc gcatgtcttg cattggctta gccgccctca cgccttgggc catcgttccc 2820
gccgctttcg gttattggct cactttaaaa acaacaaaaa gagggggcgt gttttgggac 2880
acgccatccc caaaaccttg ctcaaaagga gacaccacta caggagtcta ccgaattatg 2940
gctagaggga ttcttggcac ttaccaggcc ggcgtcggag tcatgtacga gaatgttttc 3000
cacacactat ggcacacaac tagaggagca gccattgtga gtggagaagg aaaattgacg 3060
ccatactggg gtagtgtgaa agaagaccgc atagcttacg gaggcccatg gaggtttgac 3120
cgaaaatgga atggaacaga tgacgtgcaa gtgatcgtgg tagaaccggg gaagggcgca 3180
gtaaacatcc agacaaaacc aggagtgttt cggactccct tcggggaggt tggggctgtt 3240
agtctggatt acccgcgagg aacatccggc tcacccattc tggattccaa tggagacatt 3300
ataggcctat acggcaatgg agttgagctt ggcgatggct catacgtcag cgccatcgtg 3360
cagggtgacc gtcaggagga accagtccca gaagcttaca ccccaaacat gttgagaaag 3420
agacagatga ctgtgctaga tttgcaccct ggttcaggga aaaccaggaa aattctgcca 3480
caaataatta aggacgctat ccagcagcgc ctaagaacag ctgtgttggc accgacgcgg 3540
gtggtagcag cagaaatggc agaagttttg agagggctcc cagtacgata tcaaacttca 3600
gcagtgcaga gagagcacca agggaatgaa atagtggatg tgatgtgcca cgccactctg 3660
acccatagac tgatgtcacc gaacagagtg cccaactaca acctatttgt catggatgaa 3720
gctcatttca ccgacccagc cagtatagcc gcacgaggat acattgctac caaggtggaa 3780
ttaggggagg cagcagccat ctttatgaca gcgaccccgc ctggtaccac ggatcctttt 3840
cctgactcaa atgccccaat ccatgatttg caagatgaga taccagacag ggcatggagc 3900
agtggatacg aatggatcac aaaatatgcg ggtaaaaccg tgtggtttgt ggcgagcgta 3960
aaaatgggga atgagattgc aatgtgcctc caaagagcgg ggaaaaaggt catccaactc 4020
aaccgcaagt cctatgacac agaataccca aaatgtaaga atggagactg ggattttgtc 4080
attaccaccg acatctctga aatgggggcc aacttcggtg cgagcagggt catcgactgt 4140
agaaagagcg tgaaacccac catcttagaa gagggagaag gcagagtcat cctcggaaac 4200
ccatctccca taaccagtgc aagcgcagct caacggaggg gcagagtagg cagaaacccc 4260
aatcaagttg gagatgaata ccactatggg ggggctacca gtgaagatga cagtaaccta 4320
gcccattgga cagaggcaaa gatcatgtta gacaacatac acatgcccaa tggactggtg 4380
acccagctct atggaccaga gagggaaaag gctttcacaa tggatggcga ataccgtctc 4440
agaggtgaag aaaagaaaaa cttcttagag ctgcttagga cggctgacct cccggtgtgg 4500
ctggcctaca aggtggcgtc caatggcatc cagtacaccg acagaaagtg gtgttttgat 4560
gggccgcgta cgaatgccat actggaggac aacaccgagg tagagatagt cacccggatg 4620
ggtgagagga aaatcctcaa gccgagatgg cttgatgcaa gtgtttatgc agatcaccag 4680
gccctcaagt ggttcaaaga ctttgcagca gggaagagat cagccgttag cttcatagag 4740
gtgctcggtc gcatgcctga gcatttcatg ggaaagacgc gggaagcttt agacaccatg 4800
tacttggttg caacggctga gaaaggtggg aaagcacacc gaatggctct cgaagagctg 4860
ccagatgcac tggaaaccat cacacttatt gtcgccatta ctgtgatgac aggaggattc 4920
ttcctactaa tgatgcagcg aaagggtata gggaagatgg gtcttggagc tctagtgctc 4980
acactagcta ccttcttcct gtgggcggca gaggttcctg gaaccaaaat agcagggacc 5040
ctgcagatcg ccctgctgct gatggtggtt cccatcccag aaccggaaaa acagaggtca 5100
cagacagata accaactggc ggtgtttctc atctgtgtct tgaccgtggt tggagtggtg 5160
gcagcaaacg agtacgggat gctagaaaaa accaaagcgg atctcaagag catgtttggc 5220
ggaaagacgc aggcatcagg actgactgga ttgccaagca tggcactgga cctgcgtcca 5280
gccacagcct gggcactgta tggggggagc acagtcgtgc taacccctct tctgaagcac 5340
ctgatcacgt cggaatacgt caccacatcg ctagcttcaa ttaactcaca agctggctca 5400
ttattcgtct tgccacgagg cgtgcctttt accgacctag acttgactgt tggcctcgtc 5460
ttccttggct gttggggtca agtcaccctc acaacgtttc tgacagccat ggctctggcg 5520
acacttcact atgggtacat gctccctgga tggcaagcag aagcactcag ggctgcccag 5580
agaaggacag cggctggaat aatgaagaat gccgttgttg acggaatggt cgccactgat 5640
gtgcctgaac tggaaaggac tactcctctg atgcaaaaga aagtcggaca ggtgctcctc 5700
ataggggtaa gcgtggcagc gttcctcgtc aaccctaatg tcaccactgt gagagaagca 5760
ggggtgttgg tgacggcggc tacgcttact ttgtgggaca atggagccag tgccgtttgg 5820
aattccacca cagccacggg actctgccat gtcatgcgag gtagctacct ggctggaggc 5880
tccattgctt ggactctcat caagaacgct gataagccct ccttgaaaag gggaaggcct 5940
gggggcagga cgctagggga gcattggaag gaaaaactaa atgccatgag tagagaagag 6000
ttttttaaat accggagaga ggccataatc gaggtggacc gcactgaagc acgcagggcc 6060
agacgtgaaa ataacatagt gggaggacat ccggtttcgc gaggctcagc aaaactccgt 6120
tggctcgtgg agaaaggatt tgtctcgcca ataggaaaag tcattgatct agggtgtggg 6180
cgtggaggat ggagctacta cgcagcaacc ctgaagaagg tccaggaagt cagaggatac 6240
acgaaaggtg gggcgggaca tgaagaaccg atgctcatgc agagctacgg ctggaacctg 6300
gtctccctga agagtggagt ggacgtgttt tacaaacctt cagagcccag tgataccctg 6360
ttctgtgaca taggggaatc ctccccaagt ccagaagtag aagaacaacg cacactacgc 6420
gtcctagaga tgacatctga ctggttgcac cgaggaccta gagagttctg cattaaagtt 6480
ctctgccctt acatgcccaa ggttatagaa aaaatggaag ttctgcagcg tcgcttcgga 6540
ggtgggctag tgcgtctccc cctgtcccga aactccaatc acgagatgta ttgggttagt 6600
ggagccgctg gcaatgtggt gcacgctgtg aacatgacca gccaggtatt actggggcga 6660
atggatcgca cagtgtggag agggccaaag tatgaggaag atgtcaacct agggagcgga 6720
acaagagccg tgggaaaggg agaagtccat agcaatcagg agaaaatcaa gaagagaatc 6780
cagaagctta aagaagaatt cgccacaacg tggcacaaag accctgagca tccataccgc 6840
acttggacat accacggaag ctatgaagtg aaggctactg gctcagccag ctctctcgtc 6900
aacggagtgg tgaagctcat gagcaaacct tgggacgcca ttgccaacgt caccaccatg 6960
gccatgactg acaccacccc ttttggacag caaagagttt tcaaggagaa agttgacacg 7020
aaggctcctg agccaccagc tggagccaag gaagtgctca acgagaccac caactggctg 7080
tgggcctact tgtcacggga aaaaagaccc cgcttgtgca ccaaggaaga attcattaag 7140
aaagttaaca gcaacgcggc tcttggagca gtgttcgctg aacagaatca atggagcacg 7200
gcgcgtgagg ctgtggatga cccgcggttt tgggagatgg ttgatgaaga gagggaaaac 7260
catctgcgag gagagtgtca cacatgtatc tacaacatga tgggaaaaag agagaagaag 7320
cctggagagt ttggaaaagc taaaggaagc agggccattt ggttcatgtg gcttggagca 7380
cggtatctag agtttgaagc tttggggttc ctgaatgaag accattggct gagccgagag 7440
aattcaggag gtggagtgga aggctcaggc gtccaaaagc tggggtacat cctccgtgac 7500
atagcaggaa agcaaggagg gaaaatgtac gctgatgata ccgccgggtg ggacactaga 7560
attaccagaa ctgatttaga aaatgaagct aaggtactgg agctcctaga cggtgaacac 7620
cgcatgctcg cccgagccat aattgaactg acttacaggc acaaagtggt caaggtcatg 7680
agacctgcag cagaaggaaa gaccgtgatg gacgtgatat caagagaaga tcaaaggggg 7740
agtggacagg tggtcactta tgctcttaac actttcacga acatcgctgt ccagctcgtc 7800
aggctgatgg aggctgaggg ggtcattgga ccacaacact tggaacatct acctaggaaa 7860
aacaagatag ctgtcaggac ctggctcttt gagaatggag aggagagagt gaccaggatg 7920
gcgatcagcg gagacgactg tgccgtcaaa ccgctggacg acagattcgc cacagccctc 7980
cacttcctca acgcaatgtc aaaggtcaga aaagacatcc aggaatggaa gccttcgcat 8040
ggctggcacg attggcagca agttcccttc tgttctaacc atcttcagga gattgtgatg 8100
aaagatggaa ggagtatagt tgtcccgtgc agaggacagg atgagctgat aggcagggct 8160
cgcatctctc caggagctgg atggaatgtg aaggacacag cttgcctggc caaagcatat 8220
gcacagatgt ggctactcct atacttccat cgcagggact tgcgtctcat ggcaaatgcg 8280
atttgctcag cagcgccagt agattgggtg cccacaggca ggacatcctg gtcaatacac 8340
tcgaaaggag agtggatgac cacggaagac atgctgcagg tctggaacag agtttggatt 8400
gaagaaaatg aatggatgat ggacaagact ccaatcacaa gctggacaga cgttccgtat 8460
gtgggaaagc gcgaggacat ctggtgtggc agcctcatcg gaacgcgatc cagagcaacc 8520
tgggctgaga acatctatgc ggcgataaac caggttagag ctgtcattgg gaaagaaaat 8580
tatgttgact acatgacctc actcaggaga tacgaagacg tcttgatcca ggaagacagg 8640
gtcatctagt gtgatttaag gtagaaaagt agactatgta aacaatgtaa atgagaaaat 8700
gcatgcatat ggagtcaggc cagcaaaagc tgccaccgga tactgggtag acggtgctgc 8760
ctgcgtctca gtcccaggag gactgggtta acaaatctga caacagaaag tgagaaagcc 8820
ctcagaaccg tctcggaagt aggtccctgc tcactggaag ttgaaagacc aacgtcaggc 8880
cacaaatttg tgccactccg ctagggagtg cggcctgcgc agccccagga ggactgggtt 8940
accaaagccg ttgaggcccc cacggcccaa gcctcgtcta ggatgcaata gacgaggtgt 9000
aaggactaga ggttagagga gaccccgtgg aaacaacaac atgcggccca agccccctcg 9060
aagctgtaga ggaggtggaa ggactagagg ttagaggaga ccccgcactt gcatcaaaca 9120
gcatattgac acctgggaat agactgggag atcttctgct ctatctcaac atcagctact 9180
aggcacagag cgccgaagta tgtacgtggt ggtgaggaag aacacaggat ct 9232
<210>3
<211>1983
<212>DNA
<213〉artificial sequence
<400>3
ttccatttaa ccacacgtaa cggagaacca cacatgatcg tcagtagaca agagaaaggg 60
aaaagtcttc tgtttaaaac agaggatggt gtgaacatgt gtaccctcat ggccatggac 120
cttggtgaat tgtgtgaaga tacaatcacg tacaagtgtc cttttctcag gcagaatgaa 180
ccagaagaca tagattgttg gtgcaactct acgtccacat gggtaactta tgggacgtgt 240
accaccacag gagaacacag aagagaaaaa agatcagtgg cactcgttcc acatgtggga 300
atgggactgg agacacgaac tgaaacatgg atgtcatcag aaggggcctg gaaacatgcc 360
cagagaattg aaacttggat cttgagacat ccaggcttta ccataatggc agcaatcctg 420
gcatacacca taggaacgac acatttccaa agagccctga ttttcatctt actgacagct 480
gtcgctcctt caatgacaat gcgttgcata ggaatatcaa atagagactt tgtagaaggg 540
gtttcaggag gaagctgggt tgacatagtc ttagaacatg gaagctgtgg gacgacgatg 600
gcaaaaaaca aaccaacatt ggattttgaa ctgataaaaa cagaagccaa acaacctgcc 660
actctaagga agtactgtat agaggcaaag ctgaccaaca caacaacaga ttctcgctgc 720
ccaacacaag gagaacccag cctaaatgaa gagcaggaca aaaggttcgt ctgcaaacac 780
tccatggtgg acagaggatg gggaaatgga tgtggattat ttggaaaagg aggcattgtg 840
acctgtgcta tgttcacatg caaaaagaac atgaaaggaa aagtcgtgca accagaaaac 900
ttggaataca ccattgtgat aacacctcac tcaggggaag agcatgcagt cggaaatgac 960
acaggaaaac atggcaagga aatcaaaata acaccacaga gttccatcac agaagcagag 1020
ttgacaggct atggcactgt cacgatggag tgctctccga gaacgggcct cgacttcaat 1080
gagatggtgt tgctgcaaat ggaaaataaa gcttggctgg tgcacaggca atggttccta 1140
gacctgccgt tgccatggct gcccggagcg gacacacaag gatcaaattg gatacagaaa 1200
gagacattgg tcactttcaa aaatccccat gcgaagaaac aggatgttgt tgttttggga 1260
tcccaagaag gggccatgca cacagcactc acaggggcca cagaaatcca gatgtcatca 1320
ggaaacttac tgttcacagg acatctcaag tgcaggctga ggatggacaa actacagctc 1380
aaaggaatgt catactctat gtgcacagga aagtttaaag ttgtgaagga aatagcagaa 1440
acacaacatg gaacaatagt tatcagagta caatatgaag gggacggttc tccatgtaag 1500
atcccttttg agataatgga tttggaaaaa agacatgttt taggtcgcct gattacagtc 1560
aacccaatcg taacagaaaa agatagccca gtcaacatag aagcagaacc tccattcgga 1620
gacagctaca tcatcatagg agtagagccg ggacaattga agctcaactg gtttaagaaa 1680
ggaagttcta tcggccaaat gattgagaca acaatgaggg gagcgaagag aatggccatt 1740
ttaggtgaca cagcttggga ttttggatcc ctgggaggag tgtttacatc tataggaaag 1800
gctctccacc aagttttcgg agcaatctat ggggctgcct tcagtggggt ctcatggact 1860
atgaaaatcc tcataggagt cattatcaca tggataggaa tgaattcacg cagcccctca 1920
ctgtctgtgt cactagtatt ggtgggagtc gtgacgctgt atttgggagt catggtgcag 1980
gcc 1983
<210>4
<211>1770
<212>DNA
<213〉artificial sequence
<400>4
ttccatttaa ccacacgtaa cggagaacca cacatgatcg tcagtagaca agagaaaggg 60
aaaagtcttc tgtttaaaac agaggatggt gtgaacatgt gtaccctcat ggccatggac 120
cttggtgaat tgtgtgaaga tacaatcacg tacaagtgtc cttttctcag gcagaatgaa 180
ccagaagaca tagattgttg gtgcaactct acgtccacat gggtaactta tgggacgtgt 240
accaccacag gagaacacag aagagaaaaa agatcagtgg cactcgttcc acatgtggga 300
atgggactgg agacacgaac tgaaacatgg atgtcatcag aaggggcctg gaaacatgcc 360
cagagaattg aaacttggat cttgagacat ccaggcttta ccataatggc agcaatcctg 420
gcatacacca taggaacgac acatttccaa agagccctga ttttcatctt actgacagct 480
gtcgctcctt caatgacaat gcgttgcata ggaatatcaa atagagactt tgtagaaggg 540
gtttcaggag gaagctgggt tgacatagtc ttagaacatg gaagctgtgt gacgacgatg 600
gcaaaaaaca aaccaacatt ggattttgaa ctgataaaaa cagaagccaa acaacctgcc 660
actctaagga agtactgtat agaggcaaag ctgaccaaca caacaacaga ttctcgctgc 720
ccaacacaag gagaacccag cctaaatgaa gagcaggaca aaaggttcgt ctgcaaacac 780
tccatggtgg acagaggatg gggaaatgga tgtggattat ttggaaaagg aggcattgtg 840
acctgtgcta tgttcacatg caaaaagaac atgaaaggaa aagtcgtgca accagaaaac 900
ttggaataca ccattgtgat aacacctcac tcaggggaag agcatgcagt cggaaatgac 960
acaggaaaac atggcaagga aatcaaaata acaccacaga gttccatcac agaagcagag 1020
ttgacaggct atggcactgt cacgatggag tgctctccga gaacgggcct cgacttcaat 1080
gagatggtgt tgctgcaaat ggaaaataaa gcttggctgg tgcacaggca atggttccta 1140
gacctgccgt tgccatggct gcccggagcg gacacacaag gatcaaattg gatacagaaa 1200
gagacattgg tcactttcaa aaatccccat gcgaagaaac aggatgttgt tgttttggga 1260
tcccaagaag gggccatgca cacagcactc acaggggcca cagaaatcca gatgtcatca 1320
ggaaacttac tgttcacagg acatctcaag tgcaggctga ggatggacaa actacagctc 1380
aaaggaatgt catactctat gtgcacagga aagtttaaag ttgtgaagga aatagcagaa 1440
acacaacatg gaacaatagt tatcagagta caatatgaag gggacggttc tccatgtaag 1500
atcccttttg agataatgga tttggaaaaa agacatgttt taggtcgcct gattacagtc 1560
aacccaatcg taacagaaaa agatagccca gtcaacatag aagcagaacc tccattcgga 1620
gacagctaca tcatcatagg agtagagccg ggacaattga agctcaactg gtttaagaaa 1680
ggaagttcta tcggccaaat gattgagaca acaatgaggg gagcgaagag aatggccatt 1740
ttaggtgaca cagcttggga ttttggatcc 1770
<210>5
<211>58
<212>DNA
<213〉artificial sequence
<400>5
cggaattcta atacgactca ctataggaga agtttatctg tgtgaacttc ttggctta 58
<210>6
<211>36
<212>DNA
<213〉artificial sequence
<400>6
aaaggatccg tggtaccagg cggggtcgct gtcata 36
<210>7
<211>20
<212>DNA
<213〉artificial sequence
<400>7
gccatcttta tgacagcgac 20
<210>8
<211>44
<212>DNA
<213〉artificial sequence
<400>8
cggtcgacag atcctgtgtt cttcctcacc accacgtaca tact 44
<210>9
<211>20
<212>DNA
<213〉artificial sequence
<400>9
aggagggccc ggtaaaaacc 20
<210>10
<211>43
<212>DNA
<213〉artificial sequence
<400>10
cccgggctcg aggcgcgcac cggtggctcc tgcacaagct atg 43
<210>11
<211>45
<212>DNA
<213〉artificial sequence
<400>11
accggtgcgc gcctcgagcc cggggacact ggatgtgcca ttgac 45
<210>12
<211>36
<212>DNA
<213〉artificial sequence
<400>12
aaaggatccg tggtaccagg cggggtcgct gtcata 36
<210>13
<211>44
<212>DNA
<213〉artificial sequence
<400>13
accggtgcgc gcctcgagcc cgggattgga ggggtcttca actc 44
<210>14
<211>36
<212>DNA
<213〉artificial sequence
<400>14
aaaggatccg tggtaccagg cggggtcgct gtcata 36
<210>15
<211>22
<212>DNA
<213〉artificial sequence
<400>15
aaggtgaagg tcggagtcaa cg 22
<210>16
<211>21
<212>DNA
<213〉artificial sequence
<400>16
gtccctggaa gatggtgatg g 21
<210>17
<211>21
<212>DNA
<213〉artificial sequence
<400>17
agtgaagagg gtagtaatga g 21
<210>18
<211>21
<212>DNA
<213〉artificial sequence
<400>18
ccaagttctc gtttgaaact a 21
<210>19
<211>21
<212>DNA
<213〉artificial sequence
<400>19
accggtatgg tgagcaaggg c 21
<210>20
<211>21
<212>DNA
<213〉artificial sequence
<400>20
cccgggcttg tacagctggt c 21
<210>21
<211>21
<212>DNA
<213〉artificial sequence
<400>21
accggtttcc atttaaccac a 21
<210>22
<211>21
<212>DNA
<213〉artificial sequence
<400>22
cccgggggcc tgcaccatga c 21
<210>23
<211>21
<212>DNA
<213〉artificial sequence
<400>23
accggtttcc atttaaccac a 21
<210>24
<211>26
<212>DNA
<213〉artificial sequence
<400>24
cccgggggat ccaaaatccc aagctg 26
<210>25
<211>25
<212>DNA
<213〉artificial sequence
<400>25
cgagaacttg gaacactcat tgacg 25
<210>26
<211>25
<212>DNA
<213〉artificial sequence
<400>26
gcgctttgtg gacgatcttc gctag 25

Claims (10)

1, a kind of virus replication, it comprises plasmid vector and JEV SA14-14-2 full-length cDNA genomic clone.
2, replicon as claimed in claim 1 is characterized in that, has prokaryotic promoter at the genomic 5 ' end of JEV SA14-14-2 full-length cDNA, and preferred described promotor is T7, more preferably also increases by two sweet soda acid bases of bird after described promotor.
3, replicon as claimed in claim 2 is characterized in that, has unique restriction endonuclease sites as transcribing site out of control at the genomic 3 ' end of JEV SA14-14-2 full-length cDNA.
4, replicon as claimed in claim 3 is characterized in that, described restriction enzyme site is SalI.
As each described replicon of claim 1~4, it is characterized in that 5, the 963rd VITAMIN B4 A sports thymus pyrimidine T on the ns3 gene.
6, a kind of replicon carrier, it obtains by the proteic all or part of nucleic acid of the coding prM/E of the arbitrary described replicon of claim 1~5 being replaced with multiple clone site, and described part nucleotide sequence is meant coding proteic full sequence of prM and the proteic most of sequence of coding E.
7, replicon carrier as claimed in claim 6 is characterized in that, the nucleotide sequence of described carrier is shown in SEQ ID No.1 or SEQ ID No.2.
8, a kind of embedded virus, it is the proteic all or part of nucleic acid of the coding prM/E of the arbitrary described replicon of claim 1~5 to be replaced with the proteic all or part of nucleotide sequence of dengue virus coding prM/E obtain, or inserting the proteic all or part of nucleotide sequence of dengue virus coding prM/E in the multiple clone site of claim 8 or 9 described replicon carriers obtains, and described part nucleotide sequence is meant coding proteic full sequence of prM and the proteic most of sequence of coding E.
9, embedded virus as claimed in claim 8 is characterized in that, described dengue virus is dengue virus 2 types.
10, claim 8 or the 9 described embedded viruses application in the preparation dengue virus vaccine.
CNA2009100852316A 2009-06-04 2009-06-04 Japanese encephalitis/dengue chimeric virus and application thereof Pending CN101560520A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2009100852316A CN101560520A (en) 2009-06-04 2009-06-04 Japanese encephalitis/dengue chimeric virus and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2009100852316A CN101560520A (en) 2009-06-04 2009-06-04 Japanese encephalitis/dengue chimeric virus and application thereof

Publications (1)

Publication Number Publication Date
CN101560520A true CN101560520A (en) 2009-10-21

Family

ID=41219496

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2009100852316A Pending CN101560520A (en) 2009-06-04 2009-06-04 Japanese encephalitis/dengue chimeric virus and application thereof

Country Status (1)

Country Link
CN (1) CN101560520A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101948850A (en) * 2010-08-13 2011-01-19 中国疾病预防控制中心病毒病预防控制所 Preparation method and application of virus-like particles of dengue viruses
CN102796749A (en) * 2011-05-27 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus
CN103205460A (en) * 2012-10-29 2013-07-17 成都生物制品研究所有限责任公司 Chimeric virus, and preparation method and application thereof
CN103409376A (en) * 2013-08-08 2013-11-27 中国人民解放军军事医学科学院微生物流行病研究所 JEV (Japanese Encephalitis Virus) / WNV (West Nile Virus) chimeric virus and application thereof
CN105400799A (en) * 2015-12-22 2016-03-16 成都生物制品研究所有限责任公司 Epidemic encephalitis B/yellow fever chimeric virus and preparation method and application thereof
CN108040484A (en) * 2014-12-11 2018-05-15 巴斯德研究院 Encephalitis B immunogenic composition based on slow virus carrier
CN113637086A (en) * 2013-03-15 2021-11-12 武田疫苗股份有限公司 Compositions and methods for dengue virus chimeric constructs in vaccines

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101948850A (en) * 2010-08-13 2011-01-19 中国疾病预防控制中心病毒病预防控制所 Preparation method and application of virus-like particles of dengue viruses
CN102796749A (en) * 2011-05-27 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus
CN102796749B (en) * 2011-05-27 2017-05-24 中国人民解放军军事医学科学院微生物流行病研究所 Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus
CN103205460A (en) * 2012-10-29 2013-07-17 成都生物制品研究所有限责任公司 Chimeric virus, and preparation method and application thereof
CN103205460B (en) * 2012-10-29 2016-01-06 成都生物制品研究所有限责任公司 A kind of embedded virus and its preparation method and application
CN113637086A (en) * 2013-03-15 2021-11-12 武田疫苗股份有限公司 Compositions and methods for dengue virus chimeric constructs in vaccines
CN103409376A (en) * 2013-08-08 2013-11-27 中国人民解放军军事医学科学院微生物流行病研究所 JEV (Japanese Encephalitis Virus) / WNV (West Nile Virus) chimeric virus and application thereof
CN108040484A (en) * 2014-12-11 2018-05-15 巴斯德研究院 Encephalitis B immunogenic composition based on slow virus carrier
CN108040484B (en) * 2014-12-11 2022-04-26 巴斯德研究院 Lentiviral vector-based Japanese encephalitis immunogenic compositions
CN105400799A (en) * 2015-12-22 2016-03-16 成都生物制品研究所有限责任公司 Epidemic encephalitis B/yellow fever chimeric virus and preparation method and application thereof
CN105400799B (en) * 2015-12-22 2018-12-28 成都生物制品研究所有限责任公司 A kind of hot embedded virus of encephalitis/Huang and its preparation method and application

Similar Documents

Publication Publication Date Title
Boyce et al. Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts
CN103266091B (en) A type foot-and-mouth disease recombinant vaccine strains and preparation method and application thereof
CN101560520A (en) Japanese encephalitis/dengue chimeric virus and application thereof
Puri et al. Construction of a full length infectious clone for dengue-1 virus Western Pacific, 74 strain
WO2018090994A1 (en) Temperature-sensitive attenuating strain of foot-and-mouth disease virus, construction method therefor and uses thereof
CN112063592A (en) Construction of African swine fever polygene combined deletion attenuated strain and application of attenuated strain as vaccine
CN105420261B (en) A kind of heat-resisting remodeling method of newcastle disease virus and application
CN112852761B (en) Construction of gene deletion attenuated African swine fever virus strain and application of gene deletion attenuated African swine fever virus strain as vaccine
US11534417B2 (en) Enhanced expression of RNA vectors
CN111748563A (en) Construction of African swine fever gene deletion low virulent strain and application of African swine fever gene deletion low virulent strain as vaccine
CN111744000B (en) Foot-and-mouth disease recombinant virus with reduced immunosuppressive function and preparation method and application thereof
JP2022023198A (en) Vaccines against infectious diseases caused by positive stranded rna viruses
CN115851623A (en) Construction of African swine fever MGF505-2R gene deletion attenuated strain and application of attenuated strain as vaccine
AU2003267851A1 (en) Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
Nickols et al. Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice
Wang et al. A novel viral vaccine platform based on engineered transfer RNA
CN108315306A (en) One plant height fertility swine fever virus and its construction method
Zhang et al. Long-term passage of duck Tembusu virus in BHK-21 cells generates a completely attenuated and immunogenic population with increased genetic diversity
CN109136200B (en) Recombinant infectious hematopoietic necrosis virus and construction method and application thereof
EP3549604A1 (en) Recombinant bivalent inactivated vaccine for foot-and-mouth disease and preparation method and application thereof
AU2009211379B2 (en) Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
CN117568303B (en) Oya virus RNA dependent RNA polymerase mutant, expression vector and vector composition and application thereof
Silva Jr et al. Efficient assembly of full-length infectious clone of Brazilian IBDV isolate by homologous recombination in yeast
CN117568288B (en) Method for efficiently rescuing avian coronavirus and application thereof
US10655110B2 (en) Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091021